Research: MILDE and colleagues,

Listed in Issue 72

Abstract

MILDE and colleagues, Department of Analytical Chemistry, Palack University, Olomouc, Czech Republic, analysed levels of the trace elements selenium, manganese, copper and iron in blood serum from patients with colorectal cancer .

Background

Methodology

The study involved patients with adenocarcinoma colorectal cancer and age-matched control subjects from the Moravian region of the Czech Republic. The researchers used atomic absorption spectrometry with graphite furnace atomization to analyse selenium and manganese levels and with flame atomization to analyse copper and iron levels.

Results

Colorectal cancer patients had significantly lower serum selenium levels (41.811.6 g/L) and significantly higher serum manganese (16.34.5 g/L) and iron (2.891.23 mg/L) levels compared with controls. Serum copper levels in cancer patients (0.950.28 mg/L) did not differ significantly from those of controls.

Conclusion

References

Milde D et al. Serum levels of selenium, manganese, copper, and iron in colorectal cancer patients. Biological Trace Element Research 79 (2): 107-14. Feb 2001.

Comment

The above two studies suggest the potentially powerful role of minerals including selenium in the aetiology of a number of cancers.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page